Maintenance Rituximab With mTor Inhibition After High-dose Consolidative Therapy in Lymphoma
Description
This research is being done to determine if combining an investigational drug called Everolimus with Rituximab can reduce the risk of your cancer from returning after high dose chemotherapy.